Zeinab Abd Elkhalek El Shahed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zeinab Abd Elkhalek El Shahed has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Shaimaa Abdelsadek Gouhar
Medical Biochemistry Department, Medical Research Division, National Research Centre, Dokki, 12622, Cairo, Egypt
3 shared publications - Abeer Salama
Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, 12622, Egypt
2 shared publications - Ahmed Abdel‐ Fattah Soliman
Pharmacognosy Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre (NRC), 33 El-Behouth Street, Dokki, Giza 12622, Egypt
1 shared publication - Ahmed Ahmed Noser
Organic Chemistry, Chemistry Department, Faculty of Science, Tanta University, Tanta, 31527, Egypt
1 shared publication - Ahmed Bakr Abdelwahab
Plant Advanced Technologies (PAT), 54500 Vandoeuvre-les-Nancy, France
1 shared publication - Amr Nassrallah
Biotechnology Department, Faculty of Basic and Applied Sciences, Egypt-Japan University of Science and Technology, New Borg El-Arab, Alexandria, 21934, Egypt
1 shared publication
Latest Publications
- Open Access
- 5 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (26) , 23257-23279
Design, synthesis, and anti-inflammatory evaluation of new isatin azo disperse dyes: computational studies, molecular docking, and printing performance on polyester fabrics
Novel isatin azo dyes were synthesized and characterized. They showed excellent textile properties and notable anti-inflammatory activity. DFT and docking identified 5b as the most potent candidate with strong protein interactions.
- 5 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (26) , 23257-23279
Open AccessDesign, synthesis, and anti-inflammatory evaluation of new isatin azo disperse dyes: computational studies, molecular docking, and printing performance on polyester fabrics
Novel isatin azo dyes were synthesized and characterized. They showed excellent textile properties and notable anti-inflammatory activity. DFT and docking identified 5b as the most potent candidate with strong protein interactions.
- Open Access
- 29 August 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-16
Evaluation of newly synthesized 2-(thiophen-2-yl)-1H-indole derivatives as anticancer agents against HCT-116 cell proliferation via cell cycle arrest and down regulation of miR-25
In the present study, we prepared new sixteen different derivatives. The first series were prepared (methylene)bis(2-(thiophen-2-yl)-1H-indole) derivatives which have (indole and thiophene rings) by excellent yield from the reaction (2 mmol) 2-(thiophen-2-yl)-1H-indole and (1 mmol) from aldehyde. The second series were synthesized (2-(thiophen-2-yl)-1H-indol-3-yl) methyl) aniline derivatives at a relatively low yield from multicomponent reaction of three components 2-(thiophen-2-yl)-1H-indole, N-methylaniline and desired aldehydes. The anticancer effect of the newly synthesized derivatives was determined against different cancers, colon, lung, breast and skin. The counter screening was done against normal Epithelial cells (RPE-1). The effect on cell cycle and mechanisms underlying of the antitumor effect were also studied. All new compounds were initially tested at a single dose of 100 μg/ml against this panel of 5 human tumor cell lines indicated that the compounds under investigation exhibit selective cytotoxicity against HCT-116 cell line and compounds (4g, 4a, 4c) showed potent anticancer activity against HCT-116 cell line with the inhibitory concentration IC50 values were, 7.1±0.07, 10.5± 0.07 and 11.9± 0.05 μΜ/ml respectively. Also, the active derivatives caused cell cycle arrest at the S and G2/M phase with significant(p < 0.0001) increase in the expression levels of tumor suppressors miR-30C, and miR-107 and a tremendous decrease in oncogenic miR-25, IL-6 and C-Myc levels. It is to conclude that the anticancer activity could be through direct interaction with tumor cell DNA like S-phase-dependent chemotherapy drugs. Which can interact with DNA or block DNA synthesis such as doxorubicin, cisplatin, or 5-fluorouracil and which were highly effective in killing the cancer cells. This data ensures the efficiency of the 3 analogues on inducing cell cycle arrest and preventing cancer cell growth. The altered expressions explained the molecular mechanisms through which the newly synthesized analogues exert their anticancer action.
- 29 August 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-16
Open AccessEvaluation of newly synthesized 2-(thiophen-2-yl)-1H-indole derivatives as anticancer agents against HCT-116 cell proliferation via cell cycle arrest and down regulation of miR-25
In the present study, we prepared new sixteen different derivatives. The first series were prepared (methylene)bis(2-(thiophen-2-yl)-1H-indole) derivatives which have (indole and thiophene rings) by excellent yield from the reaction (2 mmol) 2-(thiophen-2-yl)-1H-indole and (1 mmol) from aldehyde. The second series were synthesized (2-(thiophen-2-yl)-1H-indol-3-yl) methyl) aniline derivatives at a relatively low yield from multicomponent reaction of three components 2-(thiophen-2-yl)-1H-indole, N-methylaniline and desired aldehydes. The anticancer effect of the newly synthesized derivatives was determined against different cancers, colon, lung, breast and skin. The counter screening was done against normal Epithelial cells (RPE-1). The effect on cell cycle and mechanisms underlying of the antitumor effect were also studied. All new compounds were initially tested at a single dose of 100 μg/ml against this panel of 5 human tumor cell lines indicated that the compounds under investigation exhibit selective cytotoxicity against HCT-116 cell line and compounds (4g, 4a, 4c) showed potent anticancer activity against HCT-116 cell line with the inhibitory concentration IC50 values were, 7.1±0.07, 10.5± 0.07 and 11.9± 0.05 μΜ/ml respectively. Also, the active derivatives caused cell cycle arrest at the S and G2/M phase with significant(p < 0.0001) increase in the expression levels of tumor suppressors miR-30C, and miR-107 and a tremendous decrease in oncogenic miR-25, IL-6 and C-Myc levels. It is to conclude that the anticancer activity could be through direct interaction with tumor cell DNA like S-phase-dependent chemotherapy drugs. Which can interact with DNA or block DNA synthesis such as doxorubicin, cisplatin, or 5-fluorouracil and which were highly effective in killing the cancer cells. This data ensures the efficiency of the 3 analogues on inducing cell cycle arrest and preventing cancer cell growth. The altered expressions explained the molecular mechanisms through which the newly synthesized analogues exert their anticancer action.
- 31 July 2023
- Published by Egyptian Knowledge Bank in Egyptian Journal of Chemistry
- Vol. 67 (2) , 1-15
Naringin attenuates D-galactose-induced brain aging via regulation of oxidative stress markers TNF-α, NF-κβ and modulation of the neurotrophic markers PGC1-α , NT-3 AGEs, and GFAP in vivo
Aging is a global issue that we all deal with on a daily basis. The level of reliance among elderly persons everywhere increases as a result of brain aging and cognitive dysfunction. Naringin is a natural compound that showed various medicinal applications and is commonly used as an anticancer, antioxidant, and anti-inflammatory properties. The current research evaluated naringin infleunce on D-galactose (D-gal) stimulated brain aging in vivo. Mice were distriputed randomely to 4 groups (10 mice/ group): Normal group, D-gal group, Groups 3& 4: Naringin (150&300 mg/kg; orally) concurrent with D-gal for 8 weeks. Behavioral, brain biochemical, and histopathological changes were assessed. Results: Naringin treatment increased rate of discrimination in recognizing of objects , Y Maze percent fluctuation, locomotive activity, and brain levels of AMPK, LKB1, PGC1-α, nerve growth factor (neurotrophin-3; NT-3), dopamine, and serotonin with a significant decrement of brain contents of TNF-α, NF-κβ, AGEs, and GFAP compared to D-gal-treated mice. In addition, naringin ameliorated neuron degeneration. In conclusion, naringin ,with its anti-inflammatory effects , has stimulated mitochondrial biogenesis and modulated neurotrophic factors and neurotransmitters regulating nerve regeneration. Yet , naringin could be a promising drug with potential neuroprotective action against brain aging stimulated neurodegeneration.
- 31 July 2023
- Published by Egyptian Knowledge Bank in Egyptian Journal of Chemistry
- Vol. 67 (2) , 1-15
Naringin attenuates D-galactose-induced brain aging via regulation of oxidative stress markers TNF-α, NF-κβ and modulation of the neurotrophic markers PGC1-α , NT-3 AGEs, and GFAP in vivo
Aging is a global issue that we all deal with on a daily basis. The level of reliance among elderly persons everywhere increases as a result of brain aging and cognitive dysfunction. Naringin is a natural compound that showed various medicinal applications and is commonly used as an anticancer, antioxidant, and anti-inflammatory properties. The current research evaluated naringin infleunce on D-galactose (D-gal) stimulated brain aging in vivo. Mice were distriputed randomely to 4 groups (10 mice/ group): Normal group, D-gal group, Groups 3& 4: Naringin (150&300 mg/kg; orally) concurrent with D-gal for 8 weeks. Behavioral, brain biochemical, and histopathological changes were assessed. Results: Naringin treatment increased rate of discrimination in recognizing of objects , Y Maze percent fluctuation, locomotive activity, and brain levels of AMPK, LKB1, PGC1-α, nerve growth factor (neurotrophin-3; NT-3), dopamine, and serotonin with a significant decrement of brain contents of TNF-α, NF-κβ, AGEs, and GFAP compared to D-gal-treated mice. In addition, naringin ameliorated neuron degeneration. In conclusion, naringin ,with its anti-inflammatory effects , has stimulated mitochondrial biogenesis and modulated neurotrophic factors and neurotransmitters regulating nerve regeneration. Yet , naringin could be a promising drug with potential neuroprotective action against brain aging stimulated neurodegeneration.
- 25 July 2023
- Published by Springer Nature in Advances in Traditional Medicine
- Vol. 24 (1) , 265-283
Assessment of the synergistic anti-inflammatory effect of naringin/sulindac for the treatment of osteoarthritis: in vitro and in vivo
- 25 July 2023
- Published by Springer Nature in Advances in Traditional Medicine
- Vol. 24 (1) , 265-283
Assessment of the synergistic anti-inflammatory effect of naringin/sulindac for the treatment of osteoarthritis: in vitro and in vivo
- Open Access
Synthetic Analogs of Marine Alkaloid Aplysinopsin Suppress Anti-Apoptotic Protein BCL2 in Prostate Cancer
Aplysinopsins are a class of indole alkaloids that possess various pharmacological activities. Although their action has been studied in regard to many diseases, their effect on prostate cancer has not yet been examined. Therefore, we synthesized a new series of aplysinopsin analogs and investigated their cytotoxic activity against prostate cancer. Five analogs showed high antitumor activity via suppressing the expression of the anti-apoptotic gene Bcl2, simulationously increasing the expression of the pro-apoptotic genes p53, Bax and Caspase 3. The inhibition of BCL2 led to the activation of BAX, which in turn activated Caspase 3, leading to apoptosis. This dual mechanism of action via apoptosis and cell cycle arrest induction is responsible for aplysinopsin analogs antitumor activity. Hence, our newly synthesized analogs are highly promising candidates for further preclinical studies against prostate cancer.
Open AccessSynthetic Analogs of Marine Alkaloid Aplysinopsin Suppress Anti-Apoptotic Protein BCL2 in Prostate Cancer
Aplysinopsins are a class of indole alkaloids that possess various pharmacological activities. Although their action has been studied in regard to many diseases, their effect on prostate cancer has not yet been examined. Therefore, we synthesized a new series of aplysinopsin analogs and investigated their cytotoxic activity against prostate cancer. Five analogs showed high antitumor activity via suppressing the expression of the anti-apoptotic gene Bcl2, simulationously increasing the expression of the pro-apoptotic genes p53, Bax and Caspase 3. The inhibition of BCL2 led to the activation of BAX, which in turn activated Caspase 3, leading to apoptosis. This dual mechanism of action via apoptosis and cell cycle arrest induction is responsible for aplysinopsin analogs antitumor activity. Hence, our newly synthesized analogs are highly promising candidates for further preclinical studies against prostate cancer.
- 5 November 2021
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (24) , 13976-13996
Molecular docking and simulation studies of synthetic protease inhibitors against COVID-19: a computational study
COVID-19 is the most recent threat to global health. Many people preferred treatment in case of infection instead of vaccination. The inhibition of viral replication is a good strategy for the treatment of COVID-19 infection. 3CLpro and PLpro are two important viral proteases responsible for proteolysis, infection, and replication of the virus. Therefore, targeting of these two enzymes is an attractive way to deal with COVID-19. The aim of this study was to screen some synthetic protease inhibitors to determine an appropriate hit molecule against COVID-19 using molecular docking and molecular dynamic simulations. The strategy depends on docking existing synthetic compounds mostly HIV protease inhibitors against two COVID-19 proteases to identify promising drugs for the treatment of COVID-19. We used protein data bank to obtain the X-ray crystal structure of the most important COVID-19 proteases 3CL pro (PDB ID: 6M2N) and PL pro (PDB ID: 6WX4). In this conceptual context, an attempt has been made to suggest an in silico computational relationship between 50 synthetic protease inhibitors and COVID-19 proteases. Out of 50 screened compounds, the best docking scores were found for these five protease inhibitors BDBM7021, BDBM698, BDBM694, BDBM93239, BDBM700. A 100-ns MD simulation was carried out to assess the stability of COVID-19 proteases and inhibitors, revealing an average RMSD value of 0.7 and favorable binding free energy (MM-GBSA) for all complexes confirming their potency as powerful binders in the COVID-19 proteases’ binding pocket. Furthermore, the current results must be confirmed using in-vitro and in-vivo antiviral methods. Communicated by Ramaswamy H. Sarma
- 5 November 2021
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (24) , 13976-13996
Molecular docking and simulation studies of synthetic protease inhibitors against COVID-19: a computational study
COVID-19 is the most recent threat to global health. Many people preferred treatment in case of infection instead of vaccination. The inhibition of viral replication is a good strategy for the treatment of COVID-19 infection. 3CLpro and PLpro are two important viral proteases responsible for proteolysis, infection, and replication of the virus. Therefore, targeting of these two enzymes is an attractive way to deal with COVID-19. The aim of this study was to screen some synthetic protease inhibitors to determine an appropriate hit molecule against COVID-19 using molecular docking and molecular dynamic simulations. The strategy depends on docking existing synthetic compounds mostly HIV protease inhibitors against two COVID-19 proteases to identify promising drugs for the treatment of COVID-19. We used protein data bank to obtain the X-ray crystal structure of the most important COVID-19 proteases 3CL pro (PDB ID: 6M2N) and PL pro (PDB ID: 6WX4). In this conceptual context, an attempt has been made to suggest an in silico computational relationship between 50 synthetic protease inhibitors and COVID-19 proteases. Out of 50 screened compounds, the best docking scores were found for these five protease inhibitors BDBM7021, BDBM698, BDBM694, BDBM93239, BDBM700. A 100-ns MD simulation was carried out to assess the stability of COVID-19 proteases and inhibitors, revealing an average RMSD value of 0.7 and favorable binding free energy (MM-GBSA) for all complexes confirming their potency as powerful binders in the COVID-19 proteases’ binding pocket. Furthermore, the current results must be confirmed using in-vitro and in-vivo antiviral methods. Communicated by Ramaswamy H. Sarma
- 2 November 2021
- Published by Taylor & Francis in Journal of Biologically Active Products from Nature
- Vol. 11 (5-6) , 467-489
Antimicrobial, Cytotoxic, and α-Glucosidase Inhibitory Potentials Using the One Strain Many Compounds Technique for Red Sea Soft Corals Associated Fungi’ Secondary Metabolites and Chemical Composition Correlations
Aspergillus unguis SPMD-EGY (A. unguis) and Aspergillus sp. 2C1-EGY (Aspergillus sp.) were isolated from the soft corals Sinularia and Lobophyton sp in the Hurghada coast, Red Sea, Egypt. One strain many compounds (OSMAC) was applied to trigger fungal silent biosynthetic genes. The results revealed that the A. unguis static filtrate extracts (St F) of all tested media exhibited the highest antimicrobial activity (inhibition zones 18.5-30.5 mm) against S. aureus, P. aeruginosa, and C. albicans. The A. unguis shake cell extracts of media A and C exhibited the highest α-glucosidase inhibitory activity (Sh Cell, 78 and 82 %). A high degree of acetylcholinesterase enzyme inhibition was obtained from A. unguis (Sh F, 61-66 %) shake filtrate extracts. The A. unguis extracts (A St F and D St Cell) demonstrated the highest cytotoxic activity against cancer cells, namely, HepG2, MCF-7, and HCT-116 (%I: 62-95; IC50: 7.9-90.8 µg/mL). The A. unguis extracts (A St F&D St F) exhibited high cytotoxic activities against HCT116 cancer spheroids compared with cisplatin (42.2 % and 51 %, respectively, vs 32.6 % for cisplatin). The biological activities of the extracts were due to the presence of various secondary metabolites detected by GC/MS analysis. Further pharmacological studies may lead to the isolation of new antitumor compounds besides the prospective antimicrobial and α-glucosidase inhibition capacity of the active extracts. Graphical abstract
- 2 November 2021
- Published by Taylor & Francis in Journal of Biologically Active Products from Nature
- Vol. 11 (5-6) , 467-489
Antimicrobial, Cytotoxic, and α-Glucosidase Inhibitory Potentials Using the One Strain Many Compounds Technique for Red Sea Soft Corals Associated Fungi’ Secondary Metabolites and Chemical Composition Correlations
Aspergillus unguis SPMD-EGY (A. unguis) and Aspergillus sp. 2C1-EGY (Aspergillus sp.) were isolated from the soft corals Sinularia and Lobophyton sp in the Hurghada coast, Red Sea, Egypt. One strain many compounds (OSMAC) was applied to trigger fungal silent biosynthetic genes. The results revealed that the A. unguis static filtrate extracts (St F) of all tested media exhibited the highest antimicrobial activity (inhibition zones 18.5-30.5 mm) against S. aureus, P. aeruginosa, and C. albicans. The A. unguis shake cell extracts of media A and C exhibited the highest α-glucosidase inhibitory activity (Sh Cell, 78 and 82 %). A high degree of acetylcholinesterase enzyme inhibition was obtained from A. unguis (Sh F, 61-66 %) shake filtrate extracts. The A. unguis extracts (A St F and D St Cell) demonstrated the highest cytotoxic activity against cancer cells, namely, HepG2, MCF-7, and HCT-116 (%I: 62-95; IC50: 7.9-90.8 µg/mL). The A. unguis extracts (A St F&D St F) exhibited high cytotoxic activities against HCT116 cancer spheroids compared with cisplatin (42.2 % and 51 %, respectively, vs 32.6 % for cisplatin). The biological activities of the extracts were due to the presence of various secondary metabolites detected by GC/MS analysis. Further pharmacological studies may lead to the isolation of new antitumor compounds besides the prospective antimicrobial and α-glucosidase inhibition capacity of the active extracts. Graphical abstract